Skip to main content
. 2021 Feb 4;12(2):393–402. doi: 10.1002/jcsm.12676

Table 1.

Baseline characteristics related to 30 day postoperative complications according to Clavien–Dindo

Characteristics Total n = 226 (range or %) CDC 0‐III a n = 186 (range or %) CDC III b‐V n = 40 (range or %) P‐value
Age (years) 59 a (18–87) 59 a (18–86) 63 a (31–87) 0.26
Age > 70 years 58 (26) 45 (24) 13 (33) 0.32
Weight (kg) 70 a (44–160) 68 a 81 a <0.001
ECOG PS > 1 19 (8) 9 (5) 10 (25) <0.001
Ascites 72 (32) 55 (31) 17 (43) 0.02
Pleural effusion 25 (11) 18 (10) 7 (18) 0.08
FIGO stage 0.03
FIGO stage I‐II B 72 (33) 65 (37) 7 (18)
FIGO III A‐IV A 146 (67) 113 (64) 33 (83)
Entities 0.31
Ovarian‐, fallopian tube‐, peritoneal cancer 160 (71) 126 (68) 29 (73)
Endometrial cancer 35 (15) 30 (16) 5 (13)
Cervical cancer 22 (10) 16 (9) 6 (10)
Vulval‐, vaginal cancer 9 (4) 9 (5) 0 (0)
Nutritional and Functional Parameters
BMI (kg/m2) 25 a (18–55) 25 a (18–55) 29 a (21–46) <0.001
Underweight (<20 kg/m2) 23 (10) 23 (12) 0 (0)
Normal (20–24.9 kg/m2) 83 (37) 77 (41) 6 (15)
Overweight (25 ≤ 30 kg/m2) 60 (27) 44 (24) 16 (40)
Obese (>30 kg/m2) 60 (27) 42 (23) 18 (45)
Phase angle alpha < 4.75 ° 56 (26) 38 (2) 18 (49) 0.002
Extracellular mass to body cell mass index > 1.35 27 (13) 16 (9) 11 (31) 0.001
Nutritional Risk Screening 2002 ≥ 3 97 (43) 76 (41) 21 (53) 0.22
Weight loss > 10% last 3 months 24 (11) 20 (11) 4 (10) 1.00
Albumin < 35.6 g/L 26 (12) 16 (9) 10 (25) 0.01
Fat mass > 27.5 kg 70 (33) 47 (26) 23 (62) <0.001
Muscle mass < 21.8 kg 126 (58) 113 (63) 13 (35) 0.003
Skeletal muscle index < 27% 68 (32) 49 (27) 19 (51) 0.006
Age‐dependent low hand grip strength 47 (21) 32 (17) 15 (38) 0.009
Timed “Up and Go” test > 9.5 s 55 (25) 36 (20) 19 (50) <0.001

ASA, American Society of Anesthesiologists; BMI, body mass index; CDC, Clavien–Dindo classification; ECOG, Eastern Cooperative Oncology Group performance status; FIGO, International Federation of Gynecology and Obstetrics.

a

Numbers represent median values.